XERS SEC Filings | SEC Document SEARCH
Back to Search
Xeris Biopharma Holdings, Inc. (XERS)
Ticker: XERS
CIK: 0001867096
60
Filings Found (Last 1 Year)
Filter Filings
All
4
2026. 10. 1.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
4
2026. 10. 1.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 10. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
4
2026. 9. 28.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
8-K
2026. 9. 9.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 9. 1.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 9. 1.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
4
2026. 9. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 1.
Shannon John Patrick Jr (CIK 0001553595)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 1.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 12.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
10-Q
2026. 6. 30.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Quarterly report
10-Q
Open Filing
8-K
2026. 8. 6.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 8. 3.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 3.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
8-K
2026. 7. 15.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 7. 6.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
4
2026. 7. 1.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 7. 1.
KREHER NERISSA (CIK 0001741850)
Insider trading report
FORM 4
Open Filing
4
2026. 7. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
8-K
2026. 6. 29.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
8-K
2026. 6. 10.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 6. 4.
Brady James Aloysius (CIK 0001916987)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 4.
Kong Garheng (CIK 0001435183)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 3.
PERSKY MARLA (CIK 0001270354)
Insider trading report
FORM 4
Open Filing
8-K
2026. 6. 4.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 6. 4.
HALKUFF DAWN (CIK 0001743658)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 4.
BORMANN-KENNEDY BARBARA-JEAN ANNE (CIK 0001635065)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 4.
JOHNSON JOHN (CIK 0001410781)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
10-Q
2026. 3. 31.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Quarterly report
10-Q
Open Filing
8-K
2026. 5. 7.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 5. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
8-K
2026. 4. 20.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 4. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 30.
Brady James Aloysius (CIK 0001916987)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 12.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 5.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 2.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
10-K
2025. 12. 31.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Annual report
10-K
Open Filing
8-K
2026. 3. 2.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
8-K
2026. 2. 26.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 2. 24.
Nguyen Anh Tu (CIK 0002058704)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 30.
Nguyen Anh Tu (CIK 0002058704)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 30.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 30.
Pieper Steven (CIK 0001875714)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 30.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 30.
Shannon John Patrick Jr (CIK 0001553595)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 8.
McCulloch Kevin (CIK 0002031695)
Insider trading report
FORM 4
Open Filing
8-K
2026. 1. 8.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2026. 1. 5.
Shannon John Patrick Jr (CIK 0001553595)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 2.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 19.
JOHNSON JOHN (CIK 0001410781)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 12.
BORMANN-KENNEDY BARBARA-JEAN ANNE (CIK 0001635065)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 1.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
8-K
2025. 12. 1.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
4
2025. 11. 13.
Shannon John Patrick Jr (CIK 0001553595)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 11.
Hecht Beth (CIK 0001652410)
Insider trading report
FORM 4
Open Filing
10-Q
2025. 9. 30.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Quarterly report
10-Q
Open Filing
8-K
2025. 11. 6.
Xeris Biopharma Holdings, Inc. (XERS) (CIK 0001867096)
Current report
8-K
Open Filing
Previous
Page 19 of 3
Next
